Effects of immune complex formation and complement activation on circulating platelets in the primate

Primate platelets are different from rodent and rabbit platelets in that they do not express receptors for C3a or C5a or immune adherence receptors. This study assessed the effects of immune complex (IC)-induced complement activation on primate platelets in the circulation. Cynomolgus monkeys (CYN,...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 91(1999), 1 vom: 16. Apr., Seite 99-105
1. Verfasser: Birmingham, D J (VerfasserIn)
Weitere Verfasser: Hebert, L A, Shen, X P, Higgins, P, Yeh, C G, Creasey, A A
Format: Aufsatz
Sprache:English
Veröffentlicht: 1999
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Antigen-Antibody Complex gamma-Globulins Complement C3a 80295-42-7
LEADER 01000caa a22002652 4500
001 NLM101519745
003 DE-627
005 20250201070011.0
007 tu
008 231222s1999 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0339.xml 
035 |a (DE-627)NLM101519745 
035 |a (NLM)10219260 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Birmingham, D J  |e verfasserin  |4 aut 
245 1 0 |a Effects of immune complex formation and complement activation on circulating platelets in the primate 
264 1 |c 1999 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 17.05.1999 
500 |a Date Revised 14.11.2007 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Primate platelets are different from rodent and rabbit platelets in that they do not express receptors for C3a or C5a or immune adherence receptors. This study assessed the effects of immune complex (IC)-induced complement activation on primate platelets in the circulation. Cynomolgus monkeys (CYN, N = 4) immunized to bovine gamma globulin (BGG) were infused with BGG over 5 min to induce acute intravascular IC formation and complement activation. The studies were carried out under normal complement conditions (N = 12), partial complement inhibition (CAB-2 treated, N = 3), or total complement inhibition (CVF treated, N = 1). Under normal complement conditions, BGG infusion increased C3a levels from undetectable to an average of 11.9 +/- 2.6 micrograms/ml. At this time, decreases occurring in both circulating neutrophils (85 +/- 6%) and monocytes (78 +/- 6%) were significantly greater than decreases in circulating platelets (13 +/- 3%, p < 0.001). Partial complement inhibition had an equivocal effect on the BGG-induced changes in circulating leukocytes, while total complement inhibition abrogated these changes. In contrast, platelet changes were unaffected by complement inhibition. We conclude that, compared to circulating leukocytes, circulating platelets are insensitive to intravascular complement activation induced by IC in the nonhuman primate. These results contrast with previous studies in rodents which demonstrate strong effects of IC-induced intravascular complement activation on both circulating neutrophils and platelets 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
650 7 |a Antigen-Antibody Complex  |2 NLM 
650 7 |a gamma-Globulins  |2 NLM 
650 7 |a Complement C3a  |2 NLM 
650 7 |a 80295-42-7  |2 NLM 
700 1 |a Hebert, L A  |e verfasserin  |4 aut 
700 1 |a Shen, X P  |e verfasserin  |4 aut 
700 1 |a Higgins, P  |e verfasserin  |4 aut 
700 1 |a Yeh, C G  |e verfasserin  |4 aut 
700 1 |a Creasey, A A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 91(1999), 1 vom: 16. Apr., Seite 99-105  |w (DE-627)NLM098196855  |x 1521-6616  |7 nnns 
773 1 8 |g volume:91  |g year:1999  |g number:1  |g day:16  |g month:04  |g pages:99-105 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 91  |j 1999  |e 1  |b 16  |c 04  |h 99-105